|
1 Indications And Usage Delstrigo™ Is Indicated As A Complete Regimen For The Treatment Of Hiv-1 Infection In Adult Patients: With No Prior Antiretroviral Treatment History, Or To Replace The Current Antiretroviral Regimen In Those Who Are Virologically Suppressed (Hiv-1 Rna Less Than 50 Copies Per Ml) On A Stable Antiretroviral Regimen With No History Of Treatment Failure And No Known Substitutions Associated With Resistance To The Individual Components Of Delstrigo [See Clinical Studies (14) ] . Delstrigo Is A Three-Drug Combination Of Doravirine (A Non-Nucleoside Reverse Transcriptase Inhibitor [Nnrti]), Lamivudine, And Tenofovir Disoproxil Fumarate (Both Nucleoside Analogue Reverse Transcriptase Inhibitors) And Is Indicated As A Complete Regimen For The Treatment Of Hiv-1 Infection In Adult Patients: With No Antiretroviral Treatment History, Or To Replace The Current Antiretroviral Regimen In Those Who Are Virologically Suppressed (Hiv-1 Rna Less Than 50 Copies Per Ml) On A Stable Antiretroviral Regimen With No History Of Treatment Failure And No Known Substitutions Associated With Resistance To The Individual Components Of Delstrigo. ( 1 )
|